185 related articles for article (PubMed ID: 15777875)
21. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
von Euler M; Seiger A; Holmberg L; Sundström E
Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838
[TBL] [Abstract][Full Text] [Related]
22. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
23. Participation of NMDA and non-NMDA excitatory amino acid receptors in the mediation of spinal reflex potentials in rats: an in vivo study.
Farkas S; Ono H
Br J Pharmacol; 1995 Mar; 114(6):1193-205. PubMed ID: 7620709
[TBL] [Abstract][Full Text] [Related]
24. Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice.
Laudrup P; Klitgaard H
Eur J Pharmacol; 1993 Nov; 250(1):15-22. PubMed ID: 7509749
[TBL] [Abstract][Full Text] [Related]
25. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
26. Role of spinal NMDA and AMPA receptors in episodic hypertension in conscious spinal rats.
Maiorov DN; Krenz NR; Krassioukov AV; Weaver LC
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1266-74. PubMed ID: 9321815
[TBL] [Abstract][Full Text] [Related]
27. Spinal NMDA receptor involvement in expansion of dorsal horn neuronal receptive field area produced by intracutaneous histamine.
Jinks SL; Carstens E
J Neurophysiol; 1998 Apr; 79(4):1613-8. PubMed ID: 9535932
[TBL] [Abstract][Full Text] [Related]
28. Intrathecal treatment with MK-801 suppresses thermal nociceptive responses and prevents c-fos immunoreactivity induced in rat lumbar spinal cord neurons.
Huang W; Simpson RK
Neurol Res; 1999 Sep; 21(6):593-8. PubMed ID: 10491822
[TBL] [Abstract][Full Text] [Related]
29. Effect of pretreatment with intrathecal excitatory amino acid receptor antagonists on the development of pain behavior caused by plantar incision.
Pogatzki EM; Zahn PK; Brennan TJ
Anesthesiology; 2000 Aug; 93(2):489-96. PubMed ID: 10910500
[TBL] [Abstract][Full Text] [Related]
30. Domoic acid neurotoxicity in cultured cerebellar granule neurons is mediated predominantly by NMDA receptors that are activated as a consequence of excitatory amino acid release.
Berman FW; Murray TF
J Neurochem; 1997 Aug; 69(2):693-703. PubMed ID: 9231729
[TBL] [Abstract][Full Text] [Related]
31. Lack of effect of intrathecally administered N-methyl-D-aspartate receptor antagonists in a rat model for postoperative pain.
Zahn PK; Brennan TJ
Anesthesiology; 1998 Jan; 88(1):143-56. PubMed ID: 9447867
[TBL] [Abstract][Full Text] [Related]
32. N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors.
Du J; Zhou S; Coggeshall RE; Carlton SM
Neuroscience; 2003; 118(2):547-62. PubMed ID: 12699789
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of calcitonin gene-related peptide and calcitonin gene-related peptide 8-37 upon responses to N-methyl-D-aspartate or (R, S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate in spinal nociceptive neurons with knee joint input in the rat.
Ebersberger A; Charbel Issa P; Vanegas H; Schaible HG
Neuroscience; 2000; 99(1):171-8. PubMed ID: 10924961
[TBL] [Abstract][Full Text] [Related]
34. The role of non-N-methyl-D-aspartate ionotropic glutamate receptors in the spinal transmission of nociception in normal animals and animals with carrageenan inflammation.
Stanfa LC; Dickenson AH
Neuroscience; 1999; 93(4):1391-8. PubMed ID: 10501464
[TBL] [Abstract][Full Text] [Related]
35. Site-selective N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations.
Willmore CB; Bespalov AY; Beardsley PM
Neurobiol Learn Mem; 2002 Sep; 78(2):347-64. PubMed ID: 12431422
[TBL] [Abstract][Full Text] [Related]
36. NMDA and AMPA receptors evoke transmitter release from noradrenergic axon terminals in the rat spinal cord.
Sundström E; Holmberg L; Souverbie F
Neurochem Res; 1998 Dec; 23(12):1501-7. PubMed ID: 9821153
[TBL] [Abstract][Full Text] [Related]
37. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
Wrathall JR; Teng YD; Choiniere D
Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203
[TBL] [Abstract][Full Text] [Related]
38. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors.
Christoffersen CL; Meltzer LT
Neuroscience; 1995 Jul; 67(2):373-81. PubMed ID: 7545793
[TBL] [Abstract][Full Text] [Related]
39. Effects of intrathecal NMDA and AMPA receptors agonists or antagonists on antinociception of propofol.
Xu AJ; Duan SM; Zeng YM
Acta Pharmacol Sin; 2004 Jan; 25(1):9-14. PubMed ID: 14704116
[TBL] [Abstract][Full Text] [Related]
40. Involvement of spinal N-methyl-D-aspartate receptors in capsaicin-induced in vivo release of substance P in the rat dorsal horn.
Afrah AW; Stiller CO; Olgart L; Brodin E; Gustafsson H
Neurosci Lett; 2001 Dec; 316(2):83-6. PubMed ID: 11742721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
